TrialBritish journal of clinical pharmacology2020

Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti-CD38 cytolytic antibody TAK-079 in healthy subjects.

Eric R Fedyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.